Multifaceted roles of BDNF and FGF2 in human striatal primordium development: An in vitro study

Experimental Neurology

Volumn 257, Issue , 2014, Pages 130-147

  Sarchielli, Erica ^a   Marini, Mirca ^a   Ambrosini, Stefano ^a   Peri, Alessandro ^b   Mazzanti, Benedetta ^a   Pinzani, Pamela ^b   Barletta, Emanuela ^b   Ballerini, Lara ^a   Paternostro, Ferdinando ^a   Paganini, Marco ^b   Porfirio, Berardino ^b   Morelli, Annamaria ^a   Gallina, Pasquale ^b   Vannelli, Gabriella B ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fetal graft; Huntington's disease; Neurotrophins; Seladin 1; Striatal neuroblasts

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULE; FIBROBLAST GROWTH FACTOR 2; NEUROTROPHIN;

ARTICLE; AUTOCRINE EFFECT; BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PARACRINE SIGNALING; PRIMORDIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

FETAL GRAFT; HUNTINGTON'S DISEASE; NEUROTROPHINS; SELADIN-1; STRIATAL NEUROBLASTS;

ANTIGENS; ANTIGENS, CD; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORPUS STRIATUM; FETUS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HUMANS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEURITES; NEUROGLIA; NEURONS; O ANTIGENS; PROTEOGLYCANS;

EID: 84900859585     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.021     Document Type: Article

References (79)

1. Barker R.A., Mason S.L., Harrower T.P., Swain R.A., Ho A.K., Sahakian B.J., Mathur R., Elneil S., Thornton S., Hurrelbrink C., Armstrong R.J., et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2013, 84:657-665.
2. Barletta E., Mugnai G., Ruggieri S. Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. Biol. Chem. 2002, 383:189-197.
3. Bemelmans A.P., Horellou P., Pradier L., Brunet I., Colin P., Mallet J. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum. Gene Ther. 1999, 10:2987-2997.
4. Björklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 2000, 3:537-544.
5. Bjugstad K.B., Zawada W.M., Goodman S., Freed C.R. IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J. Inherit. Metab. Dis. 2001, 24:631-647.
6. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 2010, 1803:55-71.
7. Canals J.M., Pineda J.R., Torres-Peraza J.F., Bosch M., Martín-Ibañez R., Muñoz M.T., Mengod G., Ernfors P., Alberch J. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 2004, 24:7727-7739.
8. Cassens C., Kleene R., Xiao M.F., Friedrich C., Dityateva G., Schafer-Nielsen C., Schachner M. Binding of the receptor tyrosine kinase TrkB to the neural cell adhesion molecule (NCAM) regulates phosphorylation of NCAM and NCAM-dependent neurite outgrowth. J. Biol. Chem. 2010, 285:28959-28967.
9. Cavallaro U., Niedermeyer J., Fuxa M., Christofori G. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol. 2001, 3:650-657.
10. Chacon M.A., Boulanger L.M. MHC class I protein is expressed by neurons and neural progenitors in mid-gestation mouse brain. Mol. Cell. Neurosci. 2013, 52:117-127.
11. Chew S.S.L., Johnson C.S., Green C.R., Danesh-Meyer H.V. Role of connexin43 in central nervous system injury. Exp. Neurol. 2010, 225:250-261.
12. Cho S.R., Benraiss A., Chmielnicki E., Samdani A., Economides A., Goldman S.A. Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J. Clin. Invest. 2007, 117:2889-2902.
13. Clelland C.D., Barker R.A., Watts C. Cell therapy in Huntington disease. Neurosurg. Focus. 2008, 24:E9.
14. Cohen-Cory S., Kidane A.H., Shirkey N.J., Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev. Neurobiol. 2010, 70:271-288.
15. Crescioli C., Squecco R., Cosmi L., Sottili M., Gelmini S., Borgogni E., Sarchielli E., Scolletta S., Francini F., Annunziato F., et al. Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs. Exp. Cell Res. 2008, 314:1337-1350.
16. DeLean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 1978, 235:E97-E102.
17. Dunnett S.B., Rosser A.E. Stem cell transplantation for Huntington's disease. Exp. Neurol. 2007, 203:279-292.
18. Evans A.E., Kelly C.M., Precious S.V., Rosser A.E. Molecular regulation of striatal development: a review. Anat. Res. Int. 2012, (Article ID 106529). 10.1155/2012/106529.
19. Fernandez E., Schiappa R., Girault J.A., Le Novere N. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput. Biol. 2006, 2:1619-1633.
20. Fujioka H., Dairyo Y., Yasunaga K., Emoto K. Neural functions of matrix metalloproteinases: plasticity, neurogenesis, and disease. Biochem. Res. Int. 2012, (789083).
21. Gallina P., Paganini M., Lombardini L., Saccardi R., Marini M., De Cristofaro M.T., Pinzani P., Salvianti F., Crescioli C., Rita Di, et al. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp. Neurol. 2008, 213:241-244.
22. Gallina P., Paganini M., Lombardini L., Mascalchi M., Porfirio B., Gadda D., Marini M., Pinzani P., Salvianti F., Crescioli C., et al. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp. Neurol. 2010, 222:30-41.
23. Glezer I., Bittencourt J.C., Rivest S. Neuronal expression of Cd36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits. J. Comp. Neurol. 2009, 517:906-924.
24. González-Martínez D., Kim S.H., Hu Y., Guimond S., Schofield J., Winyard P., Vannelli G.B., Turnbull J., Bouloux P.M. Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J. Neurosci. 2004, 24:10384-10392.
25. Goslin K., Schreyer D.J., Skene J.H., Banker G. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones. Nature 1988, 336:672-674.
26. Greeve I., Hermans-Borgmeyer I., Brellinger C., Kasper D., Gomez-Isla T., Behl C., Levkau B., Nitsch R.M. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J. Neurosci. 2000, 20:7345-7352.
27. Grothe C., Timmer M. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res. Rev. 2007, 54:80-91.
28. Guillemot F., Zimmer C. From cradle to grave: the multiple roles of fibroblast growth factors in neural development. Neuron 2011, 71:574-588.
29. Huot P., Parent A. Dopaminergic neurons intrinsic to the striatum. J. Neurochem. 2007, 101:1441-1447.
30. Jäderstad J., Jäderstad L.M., Li J., Chintawar S., Salto C., Pandolfo M., Ourednik V., Teng Y.D., Sidman R.L., Arenas E., et al. Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5184-5189.
31. Jaworski D.M., Perez-Martinez L. Tissue inhibitor of metalloproteinase-2 (TIMP-2) expression is regulated by multiple neural differentiation signals. J. Neurochem. 2006, 98:234-247.
32. Jin K., LaFevre-Bernt M., Sun Y., Chen S., Gafni J., Crippen D., Logvinova A., Ross C.A., Greenberg D.A., Ellerby L.M. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18189-18194.
33. Kells A.P., Henry R.A., Connor B. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Ther. 2008, 15:966-977.
34. Kiss J.Z., Muller D. Contribution of the neural cell adhesion molecule to neuronal and synaptic plasticity. Rev. Neurosci. 2001, 12:297-310.
35. Ko I.K., Koichi K., Iwata H. Antibody microarray for correlating cell phenotype with surface marker. Biomaterials 2005, 26:687-696.
36. Kozubenko N., Turnovcova K., Kapcalova M., Butenko O., Anderova M., Rusnakova V., Kubista M., Hampl A., Jendelova P., Sykova E. Analysis of in vitro and in vivo characteristics of human embryonic stem cell-derived neural precursors. Cell Transplant. 2010, 19:471-486.
37. Leoni V., Mariotti C., Tabrizi S.J., Valenza M., Wild E.J., Henley S.M.D., Hobbs N.Z., Mandelli M.L., Grisoli M., Bjorkhem I., et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain 2008, 131:2851-2859.
38. Li X., Xu J., Bai Y., Wang X., Dai X., Liu Y., Zhang J., Zou J., Shen L., Li L. Isolation and characterization of neural stem cells from human fetal striatum. Biochem. Biophys. Res. Commun. 2005, 326:425-434.
39. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
40. Luciani P., Deledda C., Rosati F., Benvenuti S., Cellai I., Dichiara F., Morello M., Vannelli G.B., Danza G., Serio M., Peri A. Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology 2008, 149:4256-4266.
41. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999, 285:895-898.
42. Mai J.K., Krajewski S., Reifenberger G., Genderski B., Lensing-Höhn S., Ashwell K.W. Spatiotemporal expression gradients of the carbohydrate antigen (CD15) (Lewis X) during development of the human basal ganglia. Neuroscience 1999, 88:847-858.
43. Maneschi E., Morelli A., Filippi S., Cellai I., Comeglio P., Mazzanti B., Mello T., Calcagno A., Sarchielli E., Vignozzi L., Saad F., et al. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. J. Endocrinol. 2012, 215:347-362.
44. Maness P.F., Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat. Neurosci. 2007, 10:19-26.
45. Mazumder S., Plesca D., Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol. Biol. 2008, 414:13-21.
46. Milward E.A., Fitzsimmons C., Szklarczyk A., Conant K. The matrix metalloproteinases and CNS plasticity: an overview. J. Neuroimmunol. 2007, 187:9-19.
47. Nakao N., Odin P., Lindvall O., Brundin P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp. Neurol. 1996, 138:144-157.
48. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 2009, 10:9-22.
49. Novak M.J., Tabrizi S.J. Huntington's disease. BMJ 2010, 340:c3109.
50. Obeso J.A., Rodríguez-Oroz M.C., Benitez-Temino B., Blesa F.J., Guridi J., Marin C., Rodriguez M. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov. Disord. 2008, 23:S548-S559.
51. Ohira K., Hayashi M. A new aspect of the TrkB signaling pathway in neural plasticity. Curr. Neuropharmacol. 2009, 7:276-285.
52. Olsen B.R., Reginato A.M., Wang W. Bone development. Annu. Rev. Cell Dev. Biol. 2000, 16:191-220.
53. Paganini M., Biggeri A., Romoli A.M., Mechi C., Ghelli E., Berti V., Pradella S., Bucciantini S., Catelan D., Saccardi R., Lombardini L., Mascalchi M., Massacesi L., Porfirio B., Di Lorenzo N., Vannelli G.B., Gallina P. Fetal striatal grafting slows motor and cognitive decline of Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2013, (Electronic publication ahead of print). 10.1136/jnnp-2013-306533.
54. Palmer T.D., Ray J., Gage F.H. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol. Cell. Neurosci. 1995, 6:474-486.
55. Park H., Poo M.M. Neurotrophin regulation of neural circuit development and function. Nat. Rev. Neurosci. 2013, 14:7-23.
56. Pauly M.C., Piroth T., Döbrössy M., Nikkhah G. Restoration of the striatal circuitry: from developmental aspects toward clinical applications. Front. Cell. Neurosci. 2012, 6:743-751.
57. Perez-Martinez L., Jaworski D.M. Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J. Neurosci. 2005, 25:4917-4929.
58. Pertz O., Hodgson L., Klemke R.L., Hahn K.M. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 2006, 440:1069-1072.
59. Peschanski M., Cesaro P., Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995, 68:273-285.
60. Prochnow N., Dermietzel R. Connexons and cell adhesion: a romantic phase. Histochem. Cell Biol. 2008, 130:71-77.
61. Pruszak J., Ludwig W., Blak A., Alavian K., Isacson O. CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 2009, 27:2928-2940.
62. Rege T.A., Hagood J.S. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006, 20:1045-1554.
63. Romanelli R.G., Barni T., Maggi M., Luconi M., Failli P., Pezzatini A., Pelo E., Torricelli F., Crescioli C., Ferruzzi P., et al. Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. J. Biol. Chem. 2004, 279:117-126.
64. Rosser A.E., Kelly C.M., Dunnett S.B. Cell transplantation for Huntington's disease: practical and clinical consideration. Future Neurol. 2011, 6:45-62.
65. Sari Y. Huntington's disease: from mutant huntingtin protein to neurotrophic factor therapy. Int. J. Biomed. Sci. 2011, 7:89-100.
66. Sarnat H.B., Nochlin D., Born D.E. Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in early human fetal nervous system. Brain Dev. 1998, 20:88-94.
67. Sartor L., Negro A., Barletta E., Mugnai G., Garbisa S. Modulation of proteolytic potential and differentiation by CNTF and BDNF in two mouse neuroblastoma clones: relation to invasion. Clin. Exp. Metastasis 2002, 19:709-716.
68. Schaaf C.P., Koster J., Katsonis P., Kratz L., Shchelochkov O.A., Scaglia F., Kelley R.I., Lichtarge O., Waterham H.R., Shinawi M. Desmosterolosis-phenotypic and molecular characterization of a third case and review of the literature. Am. J. Med. Genet. A 2011, 155A:1597-1604.
69. Sinno M., Biagioni S., Ajmone-Cat M.A., Pafumi I., Caramanica P., Medda V., Tonti G., Minghetti L., Mannello F., Cacci E. The matrix metalloproteinase inhibitor marimastat promotes neural progenitor cell differentiation into neurons by gelatinase-independent TIMP-2-dependent mechanisms. Stem Cells Dev. 2013, 22:345-358.
70. Staniszewska I., Sariyer I.K., Lecht S., Brown M.C., Walsh E.M., Tuszynski G.P., Safak M., Lazarovici P., Marcinkiewicz C. Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins. J. Cell Sci. 2008, 121:504-513.
71. Swart G.W. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. Eur. J. Cell Biol. 2002, 81:313-321.
72. Tong Y., Ha T.J., Liu L., Nishimoto A., Reiner A., Goldowitz D. Spatial and temporal requirements for huntingtin (Htt) in neuronal migration and survival during brain development. J. Neurosci. 2011, 31:14794-14799.
73. Ulfig N. The ganglionic eminence-new vistas. Trends Neurosci. 2000, 23:530.
74. Urbani S., Caporale R., Lombardini L., Bosi A., Saccardi R. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cytotherapy 2006, 8:243-253.
75. Ventimiglia R., Mather P.E., Jones B.E., Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 1995, 7:213-222.
76. Vinken M., Vanhaecke T., Papeleu P., Snykers S., Henkens T., Rogiers V. Connexins and their channels in cell growth and cell death. Cell. Signal. 2006, 18:592-600.
77. Xie Y., Hayden M.R., Xu B. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J. Neurosci. 2010, 30:14708-14718.
78. Yoshimura S., Takagi Y., Harada J., Teramoto T., Thomas S.S., Waeber C., Bakowska J.C., Breakefield X.O., Moskowitz M.A. FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5874-5879.
79. Yuan S.H., Martin J., Elia J., Flippin J., Paramban R.I., Hefferan M.P., Vidal J.G., Mu Y., Killian R.L., Israel M.A., et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 2011, 6:e17540.